Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Syndax Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:SNDX | Benzinga
Syndax Pharmaceuticals Inc has a consensus price target of $36.38 based on the ratings of 16 analysts. The high is $51 issued by HC Wainwright & Co. on March 4, 2025. The low is $16 issued by Scotiabank on January 8, 2025. The 3 most-recent analyst ratings were released by JP Morgan, JP Morgan, and Citigroup on March 20, 2025, March 4, 2025, and March 4, 2025, respectively. With an average price target of $40.67 between JP Morgan, JP Morgan, and Citigroup, there's an implied 196.19% upside for Syndax Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Citigroup
HC Wainwright & Co.
Scotiabank
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Syndax Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 198.62% | JP Morgan | Anupam Rama60% | $39 → $41 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 184.05% | JP Morgan | Anupam Rama60% | $35 → $39 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 205.9% | Citigroup | Yigal Nochomovitz55% | $45 → $42 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 271.45% | HC Wainwright & Co. | Edward White53% | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 16.53% | Scotiabank | George Farmer48% | $18 → $16 | Maintains | Sector Perform | Get Alert |
| 12/10/2024 | Buy Now | 271.45% | HC Wainwright & Co. | Edward White53% | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2024 | Buy Now | 176.77% | JP Morgan | Anupam Rama60% | $33 → $38 | Maintains | Overweight | Get Alert |
| 11/19/2024 | Buy Now | 227.75% | Citigroup | Yigal Nochomovitz55% | $37 → $45 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 271.45% | HC Wainwright & Co. | Edward White53% | $49 → $51 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 256.88% | HC Wainwright & Co. | Edward White53% | $47 → $49 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 140.35% | Goldman Sachs | Chris Shibutani54% | $30 → $33 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 242.32% | HC Wainwright & Co. | Edward White53% | $45 → $47 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | 169.48% | UBS | David Dai28% | → $37 | Initiates | → Buy | Get Alert |
| 10/14/2024 | Buy Now | 198.62% | Stifel | Bradley Canino40% | $40 → $41 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | 147.63% | Citigroup | Yigal Nochomovitz55% | $30 → $34 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 227.75% | HC Wainwright & Co. | Edward White53% | $41 → $45 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 125.78% | B of A Securities | Jason Zemansky75% | $30 → $31 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 140.35% | Barclays | Peter Lawson42% | $32 → $33 | Maintains | Overweight | Get Alert |
| 08/06/2024 | Buy Now | 140.35% | JP Morgan | Anupam Rama60% | $34 → $33 | Maintains | Overweight | Get Alert |
| 08/02/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 07/30/2024 | Buy Now | 118.5% | B of A Securities | Jason Zemansky75% | $31 → $30 | Maintains | Buy | Get Alert |
| 07/29/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 169.48% | Jefferies | Kelly Shi41% | → $37 | Initiates | → Buy | Get Alert |
| 06/26/2024 | Buy Now | 205.9% | Stifel | Bradley Canino40% | $40 → $42 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 05/21/2024 | Buy Now | 147.63% | JP Morgan | Anupam Rama60% | $34 → $34 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 118.5% | Citigroup | Yigal Nochomovitz55% | $32 → $30 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 191.33% | Stifel | Bradley Canino40% | $39 → $40 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 147.63% | JP Morgan | Anupam Rama60% | $31 → $34 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | → $41 | Reiterates | Buy → Buy | Get Alert |
| 01/31/2024 | Buy Now | 67.52% | Scotiabank | George Farmer48% | $36 → $23 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 01/02/2024 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | Buy Now | 198.62% | HC Wainwright & Co. | Edward White53% | $42 → $41 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | 227.75% | Mizuho | Mara Goldstein56% | → $45 | Initiates | → Buy | Get Alert |
| 10/26/2023 | Buy Now | 162.2% | Stifel | Bradley Canino40% | $38 → $36 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | 111.22% | B of A Securities | Jason Zemansky75% | → $29 | Initiates | → Buy | Get Alert |
| 10/17/2023 | Buy Now | 176.77% | JP Morgan | Anupam Rama60% | $36 → $38 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | 118.5% | Goldman Sachs | Chris Shibutani54% | → $30 | Initiates | → Buy | Get Alert |
| 10/03/2023 | Buy Now | 103.93% | Baird | Joel Beatty69% | $32 → $28 | Maintains | Outperform | Get Alert |
| 10/02/2023 | Buy Now | 205.9% | HC Wainwright & Co. | Edward White53% | $38 → $42 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | Buy Now | 140.35% | JP Morgan | Anupam Rama60% | $36 → $33 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 176.77% | HC Wainwright & Co. | Edward White53% | → $38 | Reiterates | → Buy | Get Alert |
| 07/27/2023 | Buy Now | 184.05% | Scotiabank | George Farmer48% | → $39 | Initiates | → Sector Outperform | Get Alert |
| 07/26/2023 | Buy Now | 154.92% | Citigroup | Yigal Nochomovitz55% | $31 → $35 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | 147.63% | Barclays | Peter Lawson42% | $31 → $34 | Maintains | Overweight | Get Alert |
| 07/25/2023 | Buy Now | 205.9% | Guggenheim | Michael Schmidt57% | $40 → $42 | Maintains | Buy | Get Alert |
| 07/25/2023 | Buy Now | 162.2% | B. Riley Securities | Kalpit Patel40% | $34 → $36 | Maintains | Buy | Get Alert |
| 07/24/2023 | Buy Now | 176.77% | HC Wainwright & Co. | Edward White53% | $36 → $38 | Reiterates | Buy → Buy | Get Alert |
| 07/11/2023 | Buy Now | 191.33% | Guggenheim | Michael Schmidt57% | → $40 | Initiates | → Buy | Get Alert |
| 06/26/2023 | Buy Now | 154.92% | BTIG | Justin Zelin41% | $34 → $35 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 125.78% | Citigroup | Yigal Nochomovitz55% | $32 → $31 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 162.2% | HC Wainwright & Co. | Edward White53% | $33 → $36 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 162.2% | JP Morgan | Anupam Rama60% | $41 → $36 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 133.07% | Citigroup | Yigal Nochomovitz55% | $29 → $32 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 147.63% | Goldman Sachs | Madhu Kumar72% | $39 → $34 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 140.35% | HC Wainwright & Co. | Edward White53% | → $33 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | 169.48% | Stifel | Bradley Canino40% | → $37 | Initiates | → Buy | Get Alert |
| 01/03/2023 | Buy Now | 198.62% | JP Morgan | Anupam Rama60% | → $41 | Initiates | → Overweight | Get Alert |
| 12/12/2022 | Buy Now | 184.05% | Goldman Sachs | Madhu Kumar72% | $35 → $39 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 140.35% | HC Wainwright & Co. | Edward White53% | $31 → $33 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 154.92% | Goldman Sachs | Madhu Kumar72% | $40 → $35 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 125.78% | B. Riley Securities | Kalpit Patel40% | → $31 | Reinstates | → Buy | Get Alert |
| 05/24/2022 | Buy Now | 191.33% | Goldman Sachs | Madhu Kumar72% | $51 → $40 | Maintains | Buy | Get Alert |
| 04/11/2022 | Buy Now | 125.78% | HC Wainwright & Co. | Edward White53% | → $31 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Syndax Pharmaceuticals (SNDX) stock?
The latest price target for Syndax Pharmaceuticals (NASDAQ:SNDX) was reported by JP Morgan on March 20, 2025. The analyst firm set a price target for $41.00 expecting SNDX to rise to within 12 months (a possible 198.62% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Syndax Pharmaceuticals (SNDX)?
The latest analyst rating for Syndax Pharmaceuticals (NASDAQ:SNDX) was provided by JP Morgan, and Syndax Pharmaceuticals maintained their overweight rating.
When was the last upgrade for Syndax Pharmaceuticals (SNDX)?
There is no last upgrade for Syndax Pharmaceuticals
When was the last downgrade for Syndax Pharmaceuticals (SNDX)?
The last downgrade for Syndax Pharmaceuticals Inc happened on January 31, 2024 when Scotiabank changed their price target from $36 to $23 for Syndax Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Syndax Pharmaceuticals (SNDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Syndax Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Syndax Pharmaceuticals was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating Syndax Pharmaceuticals (SNDX) correct?
While ratings are subjective and will change, the latest Syndax Pharmaceuticals (SNDX) rating was a maintained with a price target of $39.00 to $41.00. The current price Syndax Pharmaceuticals (SNDX) is trading at is $13.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.